Efficacy analysis of self-designed Qinggan Lishi Decoction in the treatment of cervical cancer patients with chemotherapy

GUAN Wei; LI Dong; WANG Haoyun; TAO Tingting

doi:10.7619/jcmp.201921015

Journal of Clinical Medicine in Practice > 2019 > 23(21): 51-53. > DOI: 10.7619/jcmp.201921015

GUAN Wei, LI Dong, WANG Haoyun, TAO Tingting. Efficacy analysis of self-designed Qinggan Lishi Decoction in the treatment of cervical cancer patients with chemotherapy[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 51-53. DOI: 10.7619/jcmp.201921015

Citation:

PDF (481 KB)

Efficacy analysis of self-designed Qinggan Lishi Decoction in the treatment of cervical cancer patients with chemotherapy

1.
Department of Oncology, Huaiyin Hospital of Huai′an, Huai′an, Jiangsu, 223300
2.
Department of Oncology, The First People′s Hospital of Changzhou, Changzhou, Jiangsu, 213003
3.
Department of Traditional Chinese Medicine, Tianning Street Community Hospital in Changzhou, Changzhou, Jiangsu, 213003

More Information

Received Date: August 11, 2019
Accepted Date: September 24, 2019
Available Online: February 28, 2021
Published Date: November 14, 2019

Graphical Abstract

Abstract

Abstract

Objective To analyze the clinical effect of Qinggan Lishui Decoction in treatment of cervical cancer patients with chemotherapy.
Methods A total of 92 cervical cancer patients with chemotherapy were selected and randomly divided into experimental group and control group. The control group was only given chemotherapy, while the experimental group was given Qinggan Lishi Decoction on the basis of conventional chemotherapy. The change of clinical indexes was compared between the two groups.
Results Before treatment, the tumor diameter of the control group and the experimental group were (4.72±1.33) cm and (4.69±1.18) cm, respectively, which showed no significant difference between two groups (P>0.05). After treatment, the tumor diameter of the control group and the experimental group were (3.01±0.97) cm and (1.64±0.41) cm, respectively, which showed a significant difference between two groups (P < 0.05). The total effective rate of the experimental group was significantly higher than that of the control group (P < 0.05). The levels of immunoglobulin G (IgG), immunoglobulin M (IgM), immunoglobulin A (IgA), CD3⁺, CD4⁺ and CD4⁺/CD8⁺ in the experimental group were significantly better than those in the control group (P < 0.05).
Conclusion Self-designed Qinggan Lishi Decoction is effective and safe in treating cervical cancer patients with chemotherapy, which can significantly shorten the tumor diameter, improve the symptoms of cervical cancer and enhance the body′s immunity.
- cervical cancer,
- chemotherapy,
- self-designed Qinggan Lishi Decoction,
- efficacy,
- immune function,
- tumor diameter

FullText(HTML)

References (22)

References

[1]	左敏芳. 自拟清肝利湿汤治疗宫颈癌化疗患者的临床疗效[J]. 河北医学, 2019, 25(7): 1226-1231. doi: 10.3969/j.issn.1006-6233.2019.07.045
[2]	Koyuncu I, Tülüce Y, Slahaddin Qadir H, et al. Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase Ⅸ inhibitor on cervical cancer cells[J]. J Enzyme Inhib Med Chem, 2019, 34(1): 703-711. doi: 10.1080/14756366.2019.1579805
[3]	Koyuncu I, Gonel A, Durgun M, et al. Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase Ⅸ inhibitors in HeLa cancer cell line[J]. J Enzyme Inhib Med Chem, 2019, 34(1): 75-86. doi: 10.1080/14756366.2018.1524380
[4]	Han X T, Wang Q, Wang Y, et al. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer[J]. J Cell Physiol, 2019, 234(8): 14170-14180. doi: 10.1002/jcp.28113
[5]	Printz C. Cervical cancer self-sampling tests could improve access[J]. Cancer, 2019, 125(10): 1583-1583.
[6]	王茅, 徐祉君. 李发枝运用经验方治疗癌症化疗后[J]. 中医药临床杂志, 2017, 29(6): 816-818. https://www.cnki.com.cn/Article/CJFDTOTAL-AHLC201706020.htm
[7]	郎景和. 迎接子宫颈癌预防的全球挑战与机遇[J]. 中华妇产科杂志, 2002, 37(3): 129-131. doi: 10.3760/j.issn:0529-567X.2002.03.001
[8]	胡珊, 赵井苓, 张静, 等. 中医多途径特色护理方案对宫颈癌根治术后患者胃肠及膀胱功能恢复的影响[J]. 中国医药导报, 2019, 16(11): 146-149. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201911037.htm
[9]	Serkies K, Jassem J. Systemic therapy for cervical carcinoma - current status[J]. Chung - Kuo Yen Cheng Yen Chiu, 2018, 30(2): 209-221. doi: 10.21147/j.issn.1000-9604.2018.02.04
[10]	黄晓妍, 师以康. 抗肿瘤药物紫杉醇结构修饰的研究进展[J]. 山东医药, 2019, 59(15): 95-100. doi: 10.3969/j.issn.1002-266X.2019.15.027
[11]	田璐, 谭力铭, 王宏强. 紫杉醇脂质体与紫杉醇治疗乳腺癌有效性和安全性的Meta分析[J]. 中国药师, 2019, 22(1): 97-101, 105. doi: 10.3969/j.issn.1008-049X.2019.01.025
[12]	张鹤. 抗肿瘤药物紫杉醇的不良反应的临床分析[J]. 中国药物滥用防治杂志, 2019, 25(3): 153-155. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYLF201903010.htm
[13]	余长云, 刘勇, 曹华. 异黏蛋白调控鼻咽癌细胞增殖及紫杉醇耐药的研究[J]. 肿瘤防治研究, 2019, 46(1): 1-6. doi: 10.3971/j.issn.1000-8578.2019.18.1000
[14]	刘娟. 清肝利湿汤联合拉米夫定治疗肝胆湿热型乙型肝炎[J]. 临床医学, 2016, 36(7): 118-119. https://www.cnki.com.cn/Article/CJFDTOTAL-EBED201607065.htm
[15]	曹建. UGT1A1*28基因多态性与伊立替康相关毒性及化疗疗效的关系[J]. 现代肿瘤医学, 2019, 27(6): 1087-1089. doi: 10.3969/j.issn.1672-4992.2019.06.045
[16]	隋继英, 高丛, 窦明金. 伊立替康新型载药系统的研究进展[J]. 药学研究, 2019, 38(8): 490-493. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYG201908014.htm
[17]	Takashi Iwata, Azumi Miyauchi, Yukako Suga, et al. Neoadjuvant chemotherapy for locally advanced cervical cancer[J]. Chinese Journal of Cancer Research, 2016, 28(2): 235-240. doi: 10.21147/j.issn.1000-9604.2016.02.13
[18]	彭京凤, 范士怀. 足三里穴位注射治疗宫颈癌化疗引起并发症的效果观察[J/OL]. 山东医学高等专科学校学报, 2019, 41(4): 1-3.
[19]	李玲. 李发枝教授运用清肝利湿汤治疗宫颈HPV感染经验[J]. 中医研究, 2014, 27(11): 39-40. doi: 10.3969/j.issn.1001-6910.2014.11.18
[20]	Tsuda N, Watari H, Ushijima K. Chemotherapy and molecular targeting therapy for recurrent cervical cancer[J]. Chung - Kuo Yen Cheng Yen Chiu, 2016, 28(2): 241-253. doi: 10.21147/j.issn.1000-9604.2016.02.14
[21]	陈忠平, 赵立霞. 术前新辅助化疗(NACT)联合手术治疗Ⅰb2和Ⅱa期宫颈癌的疗效及不良反应[J]. 临床研究, 2019, 27(9): 24-25. doi: 10.3969/j.issn.1674-7860.2019.09.010
[22]	Qian S, Ye L, Tian Y H, et al. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study[J]. Chin J Cancer, 2017, 36(1): 24-32. doi: 10.1186/s40880-017-0191-x

[1]	XIA Dongmei, SHI Guangshun, HAN Tingting, JIN Shui. Diagnostic value of serum cysteine protease inhibitor S in patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 48-51. DOI: 10.7619/jcmp.20244596
[2]	DING Xiaorui, LU Minmin, DONG Hao. Effect and mechanism of N-acetylcysteine on methylnitrosourea-induced precancerous lesions of gastric cancer[J]. Journal of Clinical Medicine in Practice, 2025, 29(2): 6-13. DOI: 10.7619/jcmp.20245014
[3]	LAN Youling, LI Tianfa, ZHAN Yatong, CHEN Yan'e, GUAN Fuqing, YANG Yang. Effect of adjuvant therapy of Shenfu Injection on NOD-like receptor protein 3/cysteine-aspartic acid-specific protease 1 mediated pyroptosis signaling pathway and inflammatory factor levels in rats with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 3-8, 13. DOI: 10.7619/jcmp.20240909
[4]	ZHU Lin, JIANG Li, YU Long, WU Jian, YIN Mengmei, HUANG Junwen, MA Cancan. Analysis of three encephalitis cases with double positive for N-methyl-D-aspartate receptor and myelinating oligodendrocyte glycoprotein antibodies[J]. Journal of Clinical Medicine in Practice, 2024, 28(2): 49-54, 59. DOI: 10.7619/jcmp.20233266
[5]	WANG Hongfang, LI Shuhua, ZHANG Runchun, ZHANG Yanbo. Changes of cellular inflammatory factors, immune levels, myelin basic protein and neuron-specific enolase levels in cerebrospinal fluid in children with benign infantile convulsions with mild gastroenteritis and their clinical significance[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 54-57, 62. DOI: 10.7619/jcmp.20211644
[6]	XU Yijun, FU Changbiao, LIANG Jingyan, TANG Tieyu, WANG Yingge. An adult case report with anti-N-methyl-D-aspartic acid receptor antibody and anti-myelin oligodendrocyte glycoprotein antibody double positive encephalitis[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 47-49, 53. DOI: 10.7619/jcmp.20210437
[7]	FANG Sisi, LUO Lan, ZHOU Haiyin, LONG Caixia. Levels of neuron-specific enolase, myelin basic protein, S-100 protein and their clinical significance in children with viral encephalitis[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 89-91,95. DOI: 10.7619/jcmp.202017024
[8]	LI Xueling, DONG Hongfen. Correlation between levels of serum IL-18 and Caspase-3 and neonatal hypoxic ischemic encephalopathy[J]. Journal of Clinical Medicine in Practice, 2016, (3): 81-83. DOI: 10.7619/jcmp.201603025
[9]	YAN Yuping, YIN Xiangli. Correlation study on expression of survivin and caspase-3 with biological behavior in gastric carcinoma[J]. Journal of Clinical Medicine in Practice, 2013, (13): 24-26. DOI: 10.7619/jcmp.201313008
[10]	LIANG Xian-mei, ZENG Jin-rong, XIA Chun-bo. The apoptosis and caspase-3 protein expression in chronic obstructive pulmonary diseases (COPD)[J]. Journal of Clinical Medicine in Practice, 2011, (17): 30-32,36. DOI: 10.3969/j.issn.1672-2353.2011.17.010

Cited By

Get Citation

PDF

XML

Article views (225) PDF downloads (6)

Turn off MathJax

Article Contents

Abstract

References

Efficacy analysis of self-designed Qinggan Lishi Decoction in the treatment of cervical cancer patients with chemotherapy

Abstract

References

Related Articles

Catalog

Efficacy analysis of self-designed Qinggan Lishi Decoction in the treatment of cervical cancer patients with chemotherapy

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content